Body

53 drugs in development·45 companies·0 clinical trials

Drug Pipeline by Phase

Approved(15)

Drug	Company
ebanga	SAB BIOTHERAPEUTICS, INC. (SABS)
emrelis	AbbVie Inc. (ABBV)
Epicel	Vericel Corp (VCEL)
GilvetMab	Merck & Co., Inc. (MRK)
granisetron	Sana Biotechnology, Inc. (SANA)
granisetron	Amneal Pharmaceuticals, Inc. (AMRX)
nevirapine	Mylan II B.V. (MYL)
Nucynta ER and Nucynta IR	COLLEGIUM PHARMACEUTICAL, INC (COLL)
Nucynta IR	COLLEGIUM PHARMACEUTICAL, INC (COLL)
opdivo qvantig	BRISTOL MYERS SQUIBB CO (BMY)
phendimetrazine	ELITE PHARMACEUTICALS INC /NV/ (ELTP)
RHA 3	Revance Therapeutics, Inc. (RVNC)
saxenda	Novo Nordisk A/S (NVO)
trodelvy	Immunome Inc. (IMNM)
twirla	AGILE THERAPEUTICS INC (AGRX)

Phase 3(7)

Drug	Company
ACP-204	ACADIA PHARMACEUTICALS INC (ACAD)
AL050	Alector, Inc. (ALEC)
alxn2030	ALEXION PHARMACEUTICALS, INC. (ALXN)
Felzartamab	BIOGEN INC. (BIIB)
hmpl-523	HUTCHMED (China) Limited (HCM)
hrs-9231	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
mezagitamab	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)

Phase 2(9)

Drug	Company
ALXN2030	ARS Pharmaceuticals, Inc. (SPRY)
Bortezomib	ADMA BIOLOGICS, INC. (ADMA)
Bortezomib	ENANTA PHARMACEUTICALS INC (ENTA)
FT819	FATE THERAPEUTICS INC (FATE)
IGM-2644	IGM Biosciences, Inc. (IGMS)
rucosopasem manganese	Galera Therapeutics, Inc. (GRTX)
SRK-181	Scholar Rock Holding Corp (SRRK)
tarperprumig	ALEXION PHARMACEUTICALS, INC. (ALXN)
Tarperprumig	ARS Pharmaceuticals, Inc. (SPRY)

Phase 1(5)

Drug	Company
ARR-217 (MRG-007)	ArriVent BioPharma, Inc. (AVBP)
CC-97540	Merus N.V. (MRUS)
FT819	Filana Therapeutics Inc. (FLNA)
ov350	Ovid Therapeutics Inc. (OVID)
prula-cel	Adicet Bio, Inc. (ACET)

Preclinical(5)

Drug	Company
ADP050-ABC	Alector, Inc. (ALEC)
ayon	Apyx Medical Corporation (APYX)
Biopharma Services - Antibody Discovery	Twist Bioscience Corp (TWST)
CD38-Diagnostic	Coeptis Therapeutics Holdings Inc. (COEP)
CPI-182	Corvus Pharmaceuticals, Inc. (CRVS)

Unknown(9)

Drug	Company
FitYourOutfit® (FYO) Body Composition System	BIOADAPTIVES, INC. (BDPT)
Five prioritized antibody leads	Twist Bioscience Corp (TWST)
IgG protein offering	Twist Bioscience Corp (TWST)
IgG Proteins	Twist Bioscience Corp (TWST)
Next generation bispecific antibody platform	Celldex Therapeutics, Inc. (CLDX)
Praesto CH1	REPLIGEN CORP (RGEN)
Precision DNA libraries	Twist Bioscience Corp (TWST)
Recombinant VBP for SARS-CoV-2	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Vital-Q - Royal Q - CBD infused Majestic Body Cream	Bioquest Corp (BQST)

N/A(1)

Drug	Company
LockBody technology platform	Centessa Pharmaceuticals plc (CNTA)

Phase 1/Phase 2(1)

Drug	Company
cid-103	CASI Pharmaceuticals, Inc. (CASIF)

Phase 4(1)

Drug	Company
rozanolixizumab	POINT Biopharma Global Inc. (PNT)

Compare drugs

ebanga vs emrelis ebanga vs Epicel ebanga vs GilvetMab

Deep-dive into Body

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis

Body — Drugs in Development & Clinical Trials | BioSniper